Abstract:Abstract Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and has become a public health concern worldwide. The hallmark of NAFLD is hepatic steatosis. Therefore, there is an urgent need to develop new therapeutic strategies that are efficacious and have minimal side effects in hepatic steatosis and NAFLD treatment. The present study aimed to investigate the effect of dietary supplement of curcumin on high-fat diet (HFD)-induced hepatic steatosis and the underlying mechanism. Methods ApoE −/− mice were fed a normal diet, high-fat diet (HFD) or HFD supplemented with curcumin (0.1% w/w) for 16 weeks. Body and liver weight, blood biochemical. parameters, and liver lipids were measured. Intestinal permeability, hepatic steatosis and mRNA and protein expressions of TLR4-related inflammatory signaling molecule were analyzed. Results The administration of curcumin significantly prevented HFD-induced body weight gain and reduced liver weight. Curcumin attenuated hepatic steatosis along with improved serum lipid profile. Moreover, curcumin up-regulated the expression of intestinal tight junction protein zonula occluden-1 and occludin, which further improved gut barrier dysfunction and reduced circulating lipopolysaccharide levels. Curcumin also markedly down-regulated the protein expression of hepatic TLR4 and myeloid differentiation factor 88 (MyD88), inhibited p65 nuclear translocation and DNA binding activity of nuclear factor-κB (NF-κB) in the liver. In addition, the mRNA expression of hepatic tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) as well as the plasma levels of TNF-α and IL-1β were also lowered by curcumin treatment. Conclusion These results indicated that curcumin protects against HFD-induced hepatic steatosis by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation. The ability of curcumin to inhibit hepatic steatosis portrayed its potential as effective dietry intervention for NAFLD prevention.

Protective Effects of Curcumin Against Hepatic Fibrosis Induced by Carbon Tetrachloride: Modulation of High-Mobility Group Box 1, Toll-Like Receptor 4 and 2 Expression

The Effect of Lecithins Coupled Decorin Nanoliposomes on Treatment of Carbon Tetrachloride-Induced Liver Fibrosis

Effect of Curcumin on Rat Hepatic Fibrosis Induced by Carbon Tetrachoride

Inhibition by Curcumin of Multiple Sites of the Transforming Growth Factor-Beta1 Signalling Pathway Ameliorates the Progression of Liver Fibrosis Induced by Carbon Tetrachloride in Rats

Effects of curcumin on expression of collagen Ⅰ in fibrotic liver induced by carbon tetrachoride in rats

Curcumin Protects Against CCl4-induced Liver Fibrosis in Rats by Inhibiting HIF-1α Through an ERK-dependent Pathway.

Curcumin Protects Against Liver Fibrosis by Attenuating Infiltration of Gr1hi Monocytes Through Inhibition of Monocyte Chemoattractant Protein-1.

Effects of Curcumin on Expression of TGF-β1 and Caspase-3 in Hepatic Fibrotic Rats Induced by Carbon Tetrachoride

Curcumin Attenuates on Carbon Tetrachloride-Induced Acute Liver Injury in Mice via Modulation of the Nrf2/HO-1 and TGF-β1/Smad3 Pathway

Curcumin Ameliorates Intrahepatic Angiogenesis and Capillarization of the Sinusoids in Carbon Tetrachloride-Induced Rat Liver Fibrosis

Serum metabonomic analysis of protective effects of Curcuma aromatica oil on renal fibrosis rats.

Protective Effects of Curcumin Against Liver Fibrosis Through Modulating DNA Methylation

Curcumin Reduces Ly6Chi Monocyte Infiltration to Protect Against Liver Fibrosis by Inhibiting Kupffer Cells Activation to Reduce Chemokines Secretion.

Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis：A study in vitro and in vivo

The Potential Mechanism of the Anti-Liver Fibrotic Effect of Curcumin in the Gut-Liver Axis

Inhibitory effects of Curcumae Radix carbonisata-based carbon dots against liver fibrosis induced by carbon tetrachloride in mice

Curcumin Protects Against Concanavalin A-Induced Hepatitis in Mice Through Inhibiting the Cytoplasmic Translocation and Expression of High Mobility Group Box 1

A Golden Shield: The Protective Role of Curcumin Against Liver Fibrosis

Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation

C1q/tumor Necrosis Factor-Related Protein-3 Acts As a Target Treating Hepatic Fibrosis

Quercetin Attenuates the Activation of Hepatic Stellate Cells and Liver Fibrosis in Mice Through Modulation of HMGB1-TLR2/4-NF-κB Signaling Pathways.